Tarsal Tunnel Syndrome (TTS): Evidence-Based Clinical Review

1. Anatomy and Pathophysiology

• Medial calcaneal nerve (MCN) - purely sensory to the heel skin
• Medial plantar nerve (MPN) - mixed; innervates medial 3.5 digits and intrinsics
• Lateral plantar nerve (LPN) - mixed; innervates lateral 1.5 digits, Baxter's nerve (first branch of LPN) supplies the abductor digiti quinti

• Campbell's Operative Orthopaedics 15th Ed 2026, p.5024-5072

2. Etiology

• Rheumatology 2-Volume Set, Elsevier 2022, p.773; Campbell's 2026, p.5074-5081

3. Clinical Assessment

History

• Burning pain, paresthesias, or dysesthesias on the plantar foot, toes, or medial heel
• Symptoms may be nocturnal (waking patient from sleep), exertional, or at rest
• Retrograde radiation to the calf (Valleix phenomenon) in some patients
• Relief from walking (distinguishes TTS from plantar fasciitis where first-step pain is classic)
• Duration, onset (insidious vs. traumatic), aggravating/relieving factors, prior treatments

Physical Examination

Provocative Tests

• Ankle plantarflexed + foot inverted (increases tunnel pressure) + digital compression over tibial nerve
• Sensitivity 86%, Specificity 100% - highest diagnostic accuracy of any clinical test

• Maximal passive ankle dorsiflexion + eversion + simultaneous MTP joint dorsiflexion
• Hold for 5-10 seconds - reproduction of symptoms is positive
• Comparable to Phalen's test for carpal tunnel syndrome
• Campbell's Operative Orthopaedics 15th Ed 2026, p.5086-5145

4. Differential Diagnosis

• Tintinalli's Emergency Medicine, p.293-301; Rheumatology 2022, p.773; Campbell's 2026

5. Investigations

Electrodiagnostic Studies (NCS/EMG)

• Nerve conduction studies are recommended - may show prolonged distal motor latency of plantar nerves, reduced sensory nerve action potential amplitude, or slowed conduction velocity
• EMG has insufficient evidence for routine recommendation
• Critically: normal electrodiagnostics do NOT exclude TTS and are not a contraindication to surgery - up to 10-30% of TTS patients have normal studies
• Useful to exclude systemic peripheral neuropathy (which would suggest systemic rather than localized injury)
• Prolonged distal motor latencies of plantar nerves occur in ~25% of RA patients

Imaging

• First-line to exclude osseous pathology: fractures, talocalcaneal coalition, osteophytes, accessory ossicles
• Weight-bearing views assess hindfoot alignment (valgus deformity)

• Identifies the causative lesion in up to 88% of patients
• Demonstrates: ganglia, varicosities, accessory muscles, soft tissue tumors, post-traumatic heterotopic bone
• Essential for surgical planning (defines extent and location of compression)
• T1-weighted: anatomy, space-occupying lesions (lipomas, heterotopic bone)
• T2-weighted/STIR: edema, fluid-filled cysts, nerve signal change
• Shows nerve enlargement proximal to compression and flattening/signal change at the site

Axial T1 MRI: heterotopic bone (asterisk) compressing neurovascular bundle (arrow) within the tarsal tunnel - patient responded to surgical decompression and bone excision (Campbell's 2026)

• Dynamic assessment of nerve mobility and compressibility; identifies varicosities in real time
• Lower cost, no radiation, available bedside
• Operator-dependent; less comprehensive than MRI for soft tissue detail
• Increasingly used for ultrasound-guided injection to improve accuracy and reduce risk to the neurovascular bundle
• A 2025 paper (Reis Soares et al., PMID 41245551) specifically highlighted the role of USG in identifying vascular etiologies
• Campbell's 2026, p.5147-5165; Rheumatology 2022, p.3217-3219

6. Treatment

Algorithm Overview

TTS Confirmed
    ↓
Conservative (6-12 weeks)
    ↓
Failure → Corticosteroid/Anesthetic Injection (non-surgical intervention)
    ↓
Continued failure OR identifiable space-occupying lesion → Surgical decompression
    ↓
Revision surgery if initial release fails (uncommon)

A. Conservative (Non-Surgical) Management

• Night splint or CAM walker boot: 6-12 weeks of ankle immobilization
• Avoidance of aggravating activities (prolonged standing, running)

• NSAIDs (oral): reduce perineural inflammation; short-term use
• Neuropathic agents: gabapentin (300-900 mg TID), pregabalin (75-150 mg BID), amitriptyline (10-75 mg nocte) - off-label but commonly used for the neuropathic component
• Topical agents: lidocaine patches, capsaicin cream

• Wide, cushioned, comfortable shoe
• For proximal TTS: standard longitudinal arch orthosis
• For distal TTS: orthosis with relief channel in the medial arch - a standard arch support may worsen distal symptoms by increasing pressure on the terminal branches
• Custom foot orthoses to correct hindfoot valgus biomechanics

• Tibial nerve mobilization/"neural flossing" techniques
• An RCT (2025, El-Nassag et al., PMID 40368127) showed that adding tibial nerve flossing (TNF) to conventional therapy (TENS + therapeutic US + gastrocnemius stretching) produced significantly greater improvement in pain, ankle ROM, and tibial nerve conduction velocity (p<0.05) vs. conventional therapy alone over 4 weeks
• Gastrocnemius/soleus stretching to reduce tension on the nerve

B. Non-Surgical Pain Interventions (Injection Therapies)

1. Corticosteroid + Local Anesthetic Injection (First-Line Injection Therapy)

1. Palpate medial malleolus and identify posterior tibial artery pulsation; mark artery to avoid
2. Insert 25-gauge needle posterior to medial malleolus, anterior to the posterior tibial artery
3. Direct needle parallel to skin, distally at 45 degrees along the line from big toe to heel
4. Aspirate to confirm not intravascular, then inject slowly
5. Injectate: hydrocortisone 25 mg/mL or methylprednisolone 10-20 mg ± 1-2 mL local anesthetic (e.g. 1% lidocaine)

Tarsal tunnel injection: needle inserted posterior to medial malleolus, anterior to posterior tibial artery (Firestein & Kelley's Rheumatology)

• USG significantly reduces risk of inadvertent intravascular injection and tendon rupture
• Real-time visualization confirms injectate spread around the tibial nerve
• A retrospective cohort study published in Orthopedic Reviews found USG corticosteroid injection produced a mean pain reduction of ~3.6-3.9/10 (NRS) in both surgical and non-surgical groups; 63% of patients avoided surgery. Younger patients were more likely to fail conservative management

2. Hydrodissection / Nerve Release Injection Therapy

• Perineural injection with 5% dextrose (D5W) or dilute local anesthetic under ultrasound guidance
• Mechanically separates the nerve from surrounding adherent tissue/fascia
• Particularly useful in post-surgical TTS with perineural fibrosis
• Evidence is emerging; no TTS-specific RCTs, but supported by mechanism and carpal tunnel syndrome data

3. Platelet-Rich Plasma (PRP)

• Emerging option; theoretical benefit via neurotrophic and anti-inflammatory growth factors
• No TTS-specific controlled trial data available as of 2025
• Extrapolated from carpal tunnel syndrome evidence where PRP has shown benefit over corticosteroids for sustained relief at 6-12 months (Yang et al., PMID 38753671)

4. TENS (Transcutaneous Electrical Nerve Stimulation)

• Used as part of a multimodal conservative regimen
• Included in the RCT by El-Nassag et al. (2025) as standard care; beneficial for pain modulation

5. Therapeutic Ultrasound

• Phonophoresis with NSAIDs or corticosteroids directly to the tunnel
• Used adjunctively; evidence is empirical

• Firestein & Kelley's Textbook of Rheumatology, p.1050; Campbell's 2026, p.5182-5193

C. Surgical Treatment

• Failure of 6-12 weeks conservative + injection therapy
• Space-occupying lesion identified (ganglion, varicosity, tumor) - earlier surgery warranted
• Severe or progressive neurological deficit

• Identifiable MRI lesion (excision/decompression of specific cause)
• Symptom duration <1 year
• No systemic peripheral neuropathy

• Age 60-80 years
• Post-traumatic scarring within the tarsal canal
• Idiopathic TTS (no identifiable cause) - ~25% achieve little/no relief
• Protracted psychiatric illness

1. Incision from 1 cm plantar to the navicular tuberosity, bisecting the area between medial malleolus and calcaneal tuberosity, ending 1 cm anterior to Achilles tendon
2. Identify and ligate superficial veins connecting plantar and saphenous systems
3. Incise flexor retinaculum along its entire length; extend 1-2 cm of deep fascia proximal to the upper retinacular edge
4. Follow MPN and LPN beneath the abductor hallucis - both may pass through fascial slings requiring individual release
5. Excise any space-occupying lesions; correct alignment disorders
6. Use magnification, tourniquet, small scissors, and non-toothed forceps throughout

• Causes of failure: incorrect diagnosis, inadequate release, poor technique, nerve scarring
• Revision should address the specific cause; neurolysis with saphenous vein or collagen wrapping recommended for perineural scar adhesion
• Outcomes of revision are unpredictable - counsel patients accordingly
• Worsening symptoms immediately post-surgery may indicate iatrogenic nerve injury with subsequent neuroma formation
• Campbell's Operative Orthopaedics 15th Ed 2026, p.5180-5290

7. Summary Evidence Table

• Normal nerve conduction studies do NOT exclude TTS - clinical diagnosis must be primary
• MRI identifies causative lesion in up to 88% and is essential before surgery
• Distal TTS requires orthosis with a relief channel, not a standard arch support (which can worsen symptoms)
• Younger patients are more likely to fail conservative treatment and require surgery
• The Triple Compression Test (86% sensitivity, 100% specificity) is the most accurate clinical test
• Always consider "double crush" syndrome when proximal neurological pathology coexists